Considerations for the management of critical patients with thyroid disease
Main Article Content
Keywords
Thyroid Gland, Critical Care, Thyroid Diseases
Abstract
The role of the endocrine system in the homeostasis of all the body is essential, and has an impact on quality of life, prognosis and survival of patients. Although all the organs of this system are important, the thyroid gland is sizeable due to its easily accessible anatomical location and the variety of symptoms and signs that occur after it is affected. In the intensive care unit, knowledge of thyroid physiology and pathology is essential, due to the critical condition of patients and their multisystemic compromise, which is why this knowledge becomes an essential tool in the diagnostic arsenal to give a timely and effective management of these disorders. The objective of this review is to transmit in a timely and updated manner the necessary considerations for the optimal approach to patients with thyroid disease in the intensive care unit.
References
1. Imam SK. Thyroid:a general overview. En:Ahmad SI, editor. Thyroid disorders:basic science and clinical practice. Switzerland:Springer;2016. 3-10.
2. Vara Luiz H, Manita I, Portugal J. Hypothyroidism. En:Ahmad SI, editor. Thyroid disorders:basic science and clinical practice. Switzerland:Springer;2016. 117-46.
3. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-421. doi:10.1089/thy.2016.0229
4. Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. 2018 European Thyroid Association guideline for the management of Graves'hyperthyroidism. Eur Thyroid J. 2018;7(4):167-86. doi:10.1159/000490384
5. Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism:a review. JAMA. 2019;322(2):153-60. doi:10.1001/jama.2019.9052
6. Galofre-Martínez MC, Daguer-Menco A, Rodríguez-Cantillo J, Ramos-Villegas Y, Barciela E, Moscote-Salazar LR. Disfunción tiroidea en el paciente crítico:fisiopatología, evaluación y manejo. Acta Colomb Cuid Intensivo. 2019;19(3):148-53.
7. Bekkering G, Agoritsas T, Lytvyn L, Heen A, Feller M, Moutzouri E, et al. Thyroid hormones treatment for subclinical hypothyroidism:a clinical practice guideline. BMJ. 2019;365:l2006. doi:10.1136/bmj.l2006
8. Tapper MA, Francis CA, Dilworth LL, McGrowder DA. Evaluating thyroid function in the clinical laboratory. Thyroid Research and Practice. 2017;14(3):118.
9. Jacobi J. Management of endocrine emergencies in the ICU. J Pharm Pract. 2019:0897190019834771. doi:10.1177/0897190019834771
10. Chávez-Valencia V, Roa-Córdova M, Mejía-Rodríguez O, Viveros-Sandoval M, Orizaga-de la Cruz C, Aguilar-Bixano O, et al. Alteraciones tiroideas en pacientes en diálisis. Rev Med Inst Mex Seguro Soc. 2018;55(Supl 2):188-94.
11. Kim SY. Diagnosis and treatment of hypopituitarism. Endocrinol Metab. 2015;30(4):443-55.
12. Idrose AM. Acute and emergency care for thyrotoxicosis and thyroid storm. Acute Med Surg. 2015;2(3):147-57. doi:10.1002/ams2.104
13. Imam SK. Hyperthyroidism. En:Ahmad SI, editor. Thyroid disorders:basic science and clinical practice. Switzerland:Springer;2016. 147-68.
14. Rizzo LF, Mana DL, Bruno OD, Wartofsky L. Coma mixedematoso. Medicina (Buenos Aires). 2017;77(4):321-8.
15. Fitzgerald PA. Endocrine disorders. En:Papadakis MA, McPhee SJ, Rabow MW, editores. Current medical diagnosis and treatment. 57th ed. New York:McGraw-Hill;2018. 1117-221.
16. Raza SA. Thyroid emergencies. En:Ahmad SI, editor. Thyroid disordes:basic science and clinical practice. Switzerland:Springer;2016. 225-38.
17. Kim MI. Hypothyroidism in the elderly. En:Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, et al., editores. Comprehensive FREE Online Endocrinology Book. South Dartmouth:MDText.com.Inc;2017. Disponible en:https://www.ncbi.nlm.nih.gov/books/ NBK279005
18. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, et al. Guidelines for the treatment of hypothyroidism:prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670751. doi:10.1089/ thy.2014.0028
19. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis:thyroid storm. Endocrinol Metab Clin North Am. 1993;22(2):263-77. doi:10.1016/S0889-8529(18)30165-8
20. Satoh T, Isozaki O, Suzuki A, Wakino S, Iburi T, Tsuboi K, et al. 2016 Guidelines for the management of thyroid storm from the Japan Thyroid Association and Japan Endocrine Society. Endocr J. 2016:EJ16-0336. doi:10.1507/endocrj.EJ16-0336
21. Gómez-Peralta F, Velasco-Martínez P, Abreu C, Cepeda M, Fernández-Puente M. Hepatotoxicity in hyperthyroid patient after consecutive methimazole and propylthiouracil therapies. Endocrinol Diabetes Metab Case Rep. 2018;2018(1):17-0173. doi:10.1530/ EDM-17-0173
22. Sarne D. Effects of the enviroment, chemicals and drugs on thyroid function. En:Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, et al., editores. Comprehensive FREE Online Endocrinology Book. South Dartmouth:MDText.com.Inc;2016. Disponible en:https://www.ncbi.nlm.nih.gov/books/NBK285560/
23. McGonigle AM, Tobian AA, Zink JL, King KE. Perfect storm:therapeutic plasma exchange for a patient with thyroid storm. J Clin Apher. 2018;33(1):113-6. doi:10.1002/jca.21560
24. Lee S, Farwell AP. Euthyroid sick syndrome. Compr Physiol. 2016;6(2):1071-80. doi:10.1002/cphy.c150017
25. Choi YS, Shim JK, Song JW, Song Y, Yang S-Y, Kwak YL. Efficacy of perioperative oral triiodothyronine replacement therapy in patients undergoing off-pump coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 2013;27(6):1218-23. doi:10.1053/j.jvca.2013.01.027
26. DeGroot LJ. The non-thyroidal illness syndrome. En:Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K, et al., editores. Comprehensive FREE Online Endocrinology Book. South Dartmouth:MDText.com.Inc;2016. Disponible en:https://www.ncbi. nlm.nih.gov/books/NBK285570
27. Knollmann BC, Roden DM. Antiarrhythmic drugs. En:Brunton LL, Hilal-Dandan R, Knollmann BC, editores. Goodman and Gilman's. The pharmacological basis of therapeutics. New York:McGrawHill;2018. 547-84.
28. Barvalia U, Amlani B, Pathak R. Amiodarone-induced thyrotoxic thyroiditis:a diagnostic and therapeutic challenge. Case Rep Med. 2014;2014:231651. doi:10.1155/2014/231651
29. García-Sáenz M, Espinosa-Cárdenas E. Tirotoxicosis inducida por amiodarona (TIA):un reto diagnóstico y terapéutico. Rev Fac Med (Mex). 2018;61(5):24-9. Disponible en:http://www.revistafacmed.com/index.php?option=com_phocadownload&view=file&id=1072:tirotoxicosis-inducida-por-amiodarona-tia&Itemid=1
30. Bogazzi F, Tomisti L, Bartalena L, Aghini-Lombardi F, Martino E. Amiodarone and the thyroid:a 2012 update. J Endocrinol Invest. 2012;35(3):340-8. doi:10.3275/8298
31. Czarnywojtek A, Czarnocka B, Zgorzalewicz-Stachowiak M, Woliński K, Fichna M, Płazińska MT, et al. The role of antithyroglobulin, antiperoxidase and anti-TSH receptor autoantibodies in amiodarone-induced thyrotoxicosis and amiodarone-induced hypothyroidism (a two-center study). Neuroendocrinol Lett. 2015;36(7):677-81.
32. Alzahrani A, Ceresini G, Aldasouqi S. Role of ultrasonography in the differential diagnosis of thyrotoxicosis:a noninvasive, cost-effective, and widely available but underutilized diagnostic tool. Endocr Pract. 2012;18(4):567- 78. doi:10.4158/EP11170.RA
33. Andrioli M, Valcavi R. Sonography of normal and abnormal thyroid and parathyroid glands. En:Buchfelder M, Guaraldi F, editores. Imaging in endocrine disorders. Basel, Switzerland:Karger;2016. 1-15.
34. Chaudhary V, Bano S. Thyroid ultrasound. Indian J Endocrinol Metab. 2013;17(2):219-27. doi:10.4103/2230- 8210.109667
35. Hari Kumar KVS, Pasupuleti V, Jayaraman M, Abhyuday V, RayuduB R, Modi KD. Affiliations expand. Role of thyroid Doppler in differential diagnosis of thyrotoxicosis. Endocr Pract. 2009;15(1):6-9. doi:10.4158/EP.15.1.6